Clinical Trials Directory

Trials / Completed

CompletedNCT01354340

Dose Effect of Limicol on (LDL)-Cholesterol Levels

Dose Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Lescuyer Laboratory · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The principal objective of this study is to investigate the dose-effect of the Limicol food supplement on LDL-cholesterol level in moderate hypercholesterolaemia subjects.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLimicol3 tablets (Limicol) + 3 tablets (Placebo) / day during 1 month and follow-up 1 month without treatment
DIETARY_SUPPLEMENTLimicol6 tablets (Limicol) / day during 1 month and follow-up 1 month without treatment
OTHERPlacebo6 tablets (Placebo) / day during 1 month and follow-up 1 month without treatment

Timeline

Start date
2011-04-01
Primary completion
2011-12-01
Completion
2012-01-01
First posted
2011-05-16
Last updated
2012-04-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01354340. Inclusion in this directory is not an endorsement.

Dose Effect of Limicol on (LDL)-Cholesterol Levels (NCT01354340) · Clinical Trials Directory